Prevention of gentamicin-induced apoptosis with the mitochondria-targeted antioxidant mitoquinone

Carolyn P Ojano-Dirain1, Patrick J Antonelli

  • 1Department of Otolaryngology, University of Florida College of Medicine, Gainesville, Florida, USA. carolyn.ojano-dirain@ent.ufl.edu

The Laryngoscope
|September 12, 2012
PubMed
Abstract

Insights

Mitoquinone (MitoQ) reduces gentamicin-induced cell death by decreasing apoptosis. This mitochondria-targeted antioxidant does not impact gentamicin

Area of Science:

  • Cell Biology
  • Pharmacology
  • Ototoxicity Research

Background:

  • Aminoglycosides, like gentamicin, can cause hearing loss through ototoxicity.
  • Antioxidants show potential in protecting against aminoglycoside-induced hearing loss.
  • Mitoquinone (MitoQ) is a mitochondria-targeted antioxidant derivative of ubiquinone, designed for enhanced mitochondrial accumulation.

Purpose of the Study:

  • To evaluate if MitoQ can reduce gentamicin-induced apoptosis by measuring caspase-3/7 activity.
  • To assess the impact of MitoQ on the antimicrobial effectiveness of gentamicin.

Main Methods:

  • Prospective, controlled study design.
  • Broth dilution methods were used to determine gentamicin's minimum inhibitory concentrations (MICs) against Staphylococcus aureus, Haemophilus influenzae, and Pseudomonas aeruginosa, with and without MitoQ.
  • Apoptosis was assessed via caspase-3/7 activity in HEI-OC1 cells treated with gentamicin, with or without preincubation with MitoQ, idebenone, or decylTPP.

Main Results:

  • MitoQ did not alter gentamicin MICs for P. aeruginosa and H. influenzae but enhanced MICs for S. aureus.
  • Gentamicin treatment significantly reduced cell viability and increased caspase-3/7 activity, indicating apoptosis.
  • Preincubation with MitoQ significantly attenuated gentamicin-induced apoptosis more effectively than idebenone.

Conclusions:

  • MitoQ effectively reduces gentamicin-induced apoptosis in HEI-OC1 cells.
  • MitoQ does not compromise the antibiotic efficacy of gentamicin.
  • MitoQ shows promise for preventing aminoglycoside-induced ototoxicity.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...